CHA News

CDPH Alerts Providers About Drug-Resistant Infections Following Procedures in Tijuana

For COOs, quality & patient safety staff, infection preventionists

This post has been archived and contains information that may be out of date.

The California Department of Public Health (CDPH) urges California hospitals to remain on the lookout for highly drug-resistant infections in patients who have been hospitalized or had any invasive procedure in Tijuana.

The department recommends all California hospitals be vigilant to the possibility of the carbapenem-resistant Pseudomonas aeruginosa outbreak from Tijuana that was first reported by U.S. public health officials in January. Hospitals are advised to obtain cultures and perform antimicrobial susceptibility testing, as well as perform rectal screening, for carbapenemase-producing organisms when admitting patients who have a history of an overnight stay in a health care facility outside the U.S. anytime within the previous 12 months.

Five people have been hospitalized in San Diego. Of the first 20 cases identified, most had surgical site infections, and 13 required hospitalization. So far, one patient has died.